Literature DB >> 27814628

Inflammatory biomarkers of coronary heart disease.

Hongyu Li1, Kai Sun2, Ruiping Zhao3, Jiang Hu4, Zhiru Hao1, Fei Wang1, Yaojun Lu1, Fu Liu1, Yong Zhang1.   

Abstract

Coronary heart disease (CHD), characterized by inflammation and accumulation of plaques mainly comprised of lipids, calcium and inflammatory cells in the walls of coronary arteries. CHD is exacerbated by specific cardiovascular risk factors, such as obesity, diabetes mellitus, and hypertension. The current review focuses on the critical role of traditional inflammatory biomarkers, including interleukin-6, C-reactive protein (CRP), complement, CD40 and myeloperoxidase (MPO), in the pathogenesis of CHD.

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 27814628     DOI： 10.2741/4498

Source DB:  PubMed          Journal:  Front Biosci (Landmark Ed)        ISSN： 2768-6698


  11 in total

1.  Rutin inhibits coronary heart disease through ERK1/2 and Akt signaling in a porcine model.

Authors:  Lin Lv; Yucai Yao; Gang Zhao; Guiyue Zhu
Journal:  Exp Ther Med       Date:  2017-10-24       Impact factor: 2.447

2.  Immune Modulation of Cardiac Arrhythmias.

Authors:  Barry London
Journal:  Circ Res       Date:  2017-06-23       Impact factor: 17.367

Review 3.  Cardiovascular injury induced by tobacco products: assessment of risk factors and biomarkers of harm. A Tobacco Centers of Regulatory Science compilation.

Authors:  Daniel J Conklin; Suzaynn Schick; Michael J Blaha; Alex Carll; Andrew DeFilippis; Peter Ganz; Michael E Hall; Naomi Hamburg; Tim O'Toole; Lindsay Reynolds; Sanjay Srivastava; Aruni Bhatnagar
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-02-01       Impact factor: 4.733

4.  Predicting significance of COX-2 expression of peripheral blood monocyte in patients with coronary artery disease.

Authors:  Qinghua Huang; Xianming Fei; Shengbing Li; Chan Xu; Chunping Tu; Lei Jiang; Mingyi Wo
Journal:  Ann Transl Med       Date:  2019-09

5.  Effect of food intake on 92 biomarkers for cardiovascular disease.

Authors:  Magnus Dencker; Ylva Gårdinger; Ola Björgell; Joanna Hlebowicz
Journal:  PLoS One       Date:  2017-06-06       Impact factor: 3.240

6.  Long non-coding RNA MALAT1 and its target microRNA-125b associate with disease risk, severity, and major adverse cardiovascular event of coronary heart disease.

Authors:  Fanqin Lv; Liang Liu; Qiang Feng; Xuefeng Yang
Journal:  J Clin Lab Anal       Date:  2021-03-04       Impact factor: 2.352

7.  Effect of GLP-1/GLP-1R on the Polarization of Macrophages in the Occurrence and Development of Atherosclerosis.

Authors:  Li Yang; Long Chen; Dongfeng Li; Hao Xu; Jishun Chen; Xinwen Min; Meian He; Tangchun Wu; Jixin Zhong; Handong Yang; Jun Chen
Journal:  Mediators Inflamm       Date:  2021-03-27       Impact factor: 4.711

8.  Study on the Active Constituents and Molecular Mechanism of Zhishi Xiebai Guizhi Decoction in the Treatment of CHD Based on UPLC-UESI-Q Exactive Focus, Gene Expression Profiling, Network Pharmacology, and Experimental Validation.

Authors:  Yuan Liu; Xu He; Zhibiao Di; Xia Du
Journal:  ACS Omega       Date:  2022-01-28

9.  Effect of induced hypoglycemia on inflammation and oxidative stress in type 2 diabetes and control subjects.

Authors:  Hassan Kahal; Anna Halama; Ahmed Aburima; Aditya M Bhagwat; Alexandra E Butler; Johannes Graumann; Karsten Suhre; Thozhukat Sathyapalan; Stephen L Atkin
Journal:  Sci Rep       Date:  2020-03-16       Impact factor: 4.379

Review 10.  A Powerful Paradigm for Cardiovascular Risk Stratification Using Multiclass, Multi-Label, and Ensemble-Based Machine Learning Paradigms: A Narrative Review.

Authors:  Jasjit S Suri; Mrinalini Bhagawati; Sudip Paul; Athanasios D Protogerou; Petros P Sfikakis; George D Kitas; Narendra N Khanna; Zoltan Ruzsa; Aditya M Sharma; Sanjay Saxena; Gavino Faa; John R Laird; Amer M Johri; Manudeep K Kalra; Kosmas I Paraskevas; Luca Saba
Journal:  Diagnostics (Basel)       Date:  2022-03-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.